135 related articles for article (PubMed ID: 29359367)
1. Truncating mutations of TP53AIP1 gene predispose to cutaneous melanoma.
Benfodda M; Gazal S; Descamps V; Basset-Seguin N; Deschamps L; Thomas L; Lebbe C; Saiag P; Zanetti R; Sacchetto L; Chiorino G; Scatolini M; Grandchamp B; Bensussan A; Soufir N
Genes Chromosomes Cancer; 2018 Jun; 57(6):294-303. PubMed ID: 29359367
[TBL] [Abstract][Full Text] [Related]
2. Rare germline variants in known melanoma susceptibility genes in familial melanoma.
Goldstein AM; Xiao Y; Sampson J; Zhu B; Rotunno M; Bennett H; Wen Y; Jones K; Vogt A; Burdette L; Luo W; Zhu B; Yeager M; Hicks B; Han J; De Vivo I; Koutros S; Andreotti G; Beane-Freeman L; Purdue M; Freedman ND; Chanock SJ; Tucker MA; Yang XR
Hum Mol Genet; 2017 Dec; 26(24):4886-4895. PubMed ID: 29036293
[TBL] [Abstract][Full Text] [Related]
3. Germline RAD51B truncating mutation in a family with cutaneous melanoma.
Wadt KA; Aoude LG; Golmard L; Hansen TV; Sastre-Garau X; Hayward NK; Gerdes AM
Fam Cancer; 2015 Jun; 14(2):337-40. PubMed ID: 25600502
[TBL] [Abstract][Full Text] [Related]
4. A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma.
Wadt K; Choi J; Chung JY; Kiilgaard J; Heegaard S; Drzewiecki KT; Trent JM; Hewitt SM; Hayward NK; Gerdes AM; Brown KM
Pigment Cell Melanoma Res; 2012 Nov; 25(6):815-8. PubMed ID: 22889334
[TBL] [Abstract][Full Text] [Related]
5. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK
PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532
[TBL] [Abstract][Full Text] [Related]
6. Inherited susceptibility to several cancers but absence of linkage between dysplastic nevus syndrome and CDKN2A in a melanoma family with a mutation in the CDKN2A (P16INK4A) gene.
Puig S; Ruiz A; Castel T; Volpini V; Malvehy J; Cardellach F; Lynch M; Mascaro JM; Estivill X
Hum Genet; 1997 Dec; 101(3):359-64. PubMed ID: 9439668
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.
Goldstein AM; Struewing JP; Chidambaram A; Fraser MC; Tucker MA
J Natl Cancer Inst; 2000 Jun; 92(12):1006-10. PubMed ID: 10861313
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824
[TBL] [Abstract][Full Text] [Related]
9. Association of XPG rs17655G>C and XPF rs1799801T>C Polymorphisms with Susceptibility to Cutaneous Malignant Melanoma: Evidence from a Case-Control Study, Systematic Review and Meta-Analysis.
Mohammadreza Niktabar S; Alireza Dastgheib S; Heiranizadeh N; Kargar S; Raee-Ezzabadi A; Jarahzadeh MH; Mohsen Miresmaeili S; Zare-Shehneh M; Neamatzadeh H
Klin Onkol; 2020; 33(3):184-194. PubMed ID: 32683874
[TBL] [Abstract][Full Text] [Related]
10. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma.
Wei Q; Lee JE; Gershenwald JE; Ross MI; Mansfield PF; Strom SS; Wang LE; Guo Z; Qiao Y; Amos CI; Spitz MR; Duvic M
J Natl Cancer Inst; 2003 Feb; 95(4):308-15. PubMed ID: 12591987
[TBL] [Abstract][Full Text] [Related]
11. CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.
Ruiz A; Puig S; Malvehy J; Lázaro C; Lynch M; Gimenez-Arnau AM; Puig L; Sánchez-Conejo J; Estivill X; Castel T
J Med Genet; 1999 Jun; 36(6):490-3. PubMed ID: 10874641
[TBL] [Abstract][Full Text] [Related]
12. Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.
Lubbe SJ; Escott-Price V; Brice A; Gasser T; Pittman AM; Bras J; Hardy J; Heutink P; Wood NM; Singleton AB; Grosset DG; Carroll CB; Law MH; Demenais F; Iles MM; ; Bishop DT; Newton-Bishop J; Williams NM; Morris HR;
Neurobiol Aging; 2016 Dec; 48():222.e1-222.e7. PubMed ID: 27640074
[TBL] [Abstract][Full Text] [Related]
13. Blood DNA methylation, nevi number, and the risk of melanoma.
Pergoli L; Favero C; Pfeiffer RM; Tarantini L; Calista D; Cavalleri T; Angelici L; Consonni D; Bertazzi PA; Pesatori AC; Landi MT; Bollati V
Melanoma Res; 2014 Oct; 24(5):480-7. PubMed ID: 25026000
[TBL] [Abstract][Full Text] [Related]
14. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
[TBL] [Abstract][Full Text] [Related]
15. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the syntaxin 17 gene are not associated with human cutaneous malignant melanoma.
Zhao ZZ; Duffy DL; Thomas SA; Martin NG; Hayward NK; Montgomery GW
Melanoma Res; 2009 Apr; 19(2):80-6. PubMed ID: 19209086
[TBL] [Abstract][Full Text] [Related]
18. Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.
Yang XR; Pfeiffer RM; Wheeler W; Yeager M; Chanock S; Tucker MA; Goldstein AM
Int J Cancer; 2009 Dec; 125(12):2912-7. PubMed ID: 19626699
[TBL] [Abstract][Full Text] [Related]
19. Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin.
Kadouri L; Temper M; Grenader T; Abeliovich D; Hamburger T; Peretz T; Lotem M
Fam Cancer; 2009; 8(1):29-32. PubMed ID: 18679827
[TBL] [Abstract][Full Text] [Related]
20. Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.
Asadian F; Niktabar SM; Ghelmani Y; Kargar S; Akbarian E; Emarati SA; Sadeghizadeh-Yazdi J; Neamatzadeh H
Acta Medica (Hradec Kralove); 2020; 63(3):101-112. PubMed ID: 33002396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
